Selentus Science Limited

Selentus develops innovative haemostatic technologies for better surgical outcomes. Selentus is developing a pipeline of products based on its unique technology platform that offer high performance, low cost manufacture and avoid the use of blood-derived materials. Selentus' lead product, TenaTac®, was approved for sale in Europe in September 2019.
Social Link - Linkedin: http://www. linkedin.com/company /selentus
Employee Count: 4
Keywords: hospital & health care